Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

Leukemia

Volumn 21, Issue 4, 2007, Pages 678-686

  Matsuda, A ^a   Germing, U ^b   Jinnai, I ^a   Iwanaga, M ^c   Misumi, M ^a   Kuendgen, A ^b   Strupp, C ^b   Miyazaki, Y ^c   Tsushima, H ^c   Sakai, M ^c   Bessho, M ^a   Gattermann, N ^b   Aul, C ^d   Tomonaga, M ^c  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^d ST JOHANNES HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FAB CLASSIFICATION; FEMALE; GRANULOPOIESIS; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; JAPANESE; LEUKOCYTE DISORDER; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA; REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA; SCORING SYSTEM; UNIVARIATE ANALYSIS; WORLD HEALTH ORGANIZATION;

EID: 33947358681     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404571     Document Type: Article

References (15)

1. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 1992; 19: 4-13.
2. Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 607-617.
3. Koeffler HP. Introduction: Myelodysplastic syndromes. Semin Hematol 1996; 33: 87-94.
4. Hofmann WK, Ottmann OG, Ganser A, Hoelzer D. Myelodysplastic syndromes: clinical features. Semin Hematol 1996; 33: 177-185.
5. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079-2088.
6. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.) World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001.
7. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: A retrospective analysis of 1600 patients. Leuk Res 2000; 24: 983-992.
8. Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R et al. Refractory cytopenia with multilineage dysplasia: Further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia 1996; 10: 20-26.
9. Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: Comparison of FAB and WHO classifications. Leuk Res 2004; 28: 587-594.
10. Matsuda A, Jinnai I, Yagasaki F, Kusumoto S, Minamihisamatsu S, Honda S et al. Refractory anemia with severe dysplasia: Clinical significance of morphological features in refractory anemia. Leukemia 1998; 12: 482-485.
11. Matsuda A, Jinnai I, Yagasaki F, Kusumoto S, Murohashi I, Bessho M et al. New system for assessing the prognosis of refractory anemia patients. Leukemia 1999; 13: 1727-1734.
12. Matsuda A, Germing U, Jinnai I, Misumi M, Kuendgen A, Knipp S et al. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 2005; 106: 2633-2640.
13. Germing U, Gattermann N, Aivado M, Hildebrandt B, Aul C. Two types of acquired idiopathic sideroblastic anaemia (AISA): A time-tested distinction. Br J Haematol 2000; 108: 724-728.
14. Nosslinger T, Reisner R, Koller E, Gruner H, Tuchler H, Nowotny H et al. Myelodysplastic syndromes, from French-American-British to World Health Organization: Comparison of classifications on 431 unselected patients from a single institution. Blood 2001; 98: 2935-2941.
15. Kuriyama K, Tomonaga M, Matsuo T, Ginnai I, Ichimaru M. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol 1986; 63: 665-669.